Medicare Enrolled

Dr. Matthew Nagorsky, MD

Otolaryngology · Philadelphia, PA
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Speaking/Promotional
205 N BROAD ST, Philadelphia, PA 19107
2157624600
In practice since 2006 (20 years)
NPI: 1780655738 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Nagorsky from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Nagorsky? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Nagorsky

Dr. Matthew Nagorsky is an otolaryngology specialist in Philadelphia, PA, with 20 years of NPI registration. Based on federal Medicare data, Dr. Nagorsky performed 4,453 Medicare services across 2,631 unique beneficiaries.

Between the years covered by Open Payments, Dr. Nagorsky received a total of $70,239 from 41 pharmaceutical and/or device companies across 395 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in otolaryngology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Nagorsky is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice ▲ Top 4% volume in PA $70,239 industry payments

Medicare Practice Summary

Medicare Utilization ↗
4,453
Medicare services
Top 4% in PA for otolaryngology
2,631
Unique beneficiaries
$102
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~223 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Nasal endoscopy
A diagnostic procedure that uses a thin, lighted tube to examine the inside of the nasal passages.
1,488 $159 $400
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
1,416 $73 $120
Ear wax removal
A procedure to remove impacted ear wax from the ear canal.
702 $22 $75
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
176 $132 $220
Flexible laryngoscopy
A diagnostic exam of the voice box using a flexible endoscope to visualize the larynx.
161 $108 $250
Office visit, established patient (10-19 min)
An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition.
140 $44 $95
Bronchoscopy through tracheostomy
Examination of the windpipe and lung airways using a flexible tube with a camera inserted through a permanent opening in the neck.
78 $116 $450
Microscopic ear examination
A detailed visual inspection of the ear using a specialized microscope to examine the ear canal and eardrum.
64 $24 $55
Complex removal of skin debris and drainage of mastoid cavity
This procedure involves the intricate removal of accumulated skin debris and the drainage of fluid from the mastoid cavity.
60 $243 $475
Endoscopic nasal polyp biopsy or removal
A procedure to remove or sample nasal polyps or tissue using an endoscope. The endoscope allows the provider to view the nasal passages during the procedure.
30 $302 $795
Endoscopic control of nosebleed
A procedure to stop bleeding in the nose using an endoscope to visualize the area.
29 $212 $500
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
29 $102 $170
Change of breathing tube in windpipe 24 $15 $150
Vocal cord movement assessment with endoscope
This procedure uses an endoscope to examine the movement of the vocal cords. It allows for the visual assessment of how the vocal cord flaps function.
22 $168 $350
New patient office visit (30-44 min)
An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range.
20 $95 $150
Initial hospital admission, moderate complexity
Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter.
14 $109 $400
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$70,239
Total received (2018-2024)
Avg $10,034/year across 7 years
Top 2% in PA for otolaryngology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
41
Companies
395
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$64,157 (91.3%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$6,082 (8.7%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$24,595
2023
$19,387
2022
$11,885
2021
$8,265
2020
$4,726
2019
$523
2018
$859

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
GENZYME CORPORATION
$19,041
Regeneron Healthcare Solutions, Inc.
$4,575
Regeneron Pharmaceuticals, Inc.
$290
Optinose US, Inc.
$200
GlaxoSmithKline, LLC.
$178
Phathom Pharmaceuticals, Inc.
$155
Inspire Medical Systems, Inc.
$77
Medtronic, Inc.
$39
AERIN MEDICAL INC.
$22
Hikma Pharmaceuticals USA
$18
Top 3 companies account for 97.2% of 2024 payments
All-time payments by company (2018-2024) ›
GENZYME CORPORATION
$46,652
Regeneron Healthcare Solutions, Inc.
$17,583
Optinose US, Inc.
$1,110
OptiNose US, Inc.
$945
GlaxoSmithKline, LLC.
$763
Regeneron Pharmaceuticals, Inc.
$522
Intersect ENT, Inc.
$273
ALK-Abello, Inc
$260
Medtronic, Inc.
$221
ARBOR PHARMACEUTICALS, INC.
$214
Stryker Corporation
$174
Freudenberg Medical, LLC
$168
Phathom Pharmaceuticals, Inc.
$155
Inspire Medical Systems, Inc.
$148
Cochlear Americas
$128
Hikma Pharmaceuticals USA
$94
JAZZ PHARMACEUTICALS INC.
$54
Merz Pharmaceuticals, LLC
$52
Arbor Pharmaceuticals, Inc.
$52
Medical Device Business Services, Inc.
$49
Merz North America, Inc.
$47
Acclarent, Inc
$45
MED-EL Corporation
$45
SANOFI-AVENTIS U.S. LLC
$44
Aerin Medical Inc.
$41
AERIN MEDICAL INC.
$41
Oticon Medical, LLC
$39
Smith & Nephew, Inc.
$38
BAXTER HEALTHCARE
$31
Covidien LP
$30
Davol Inc.
$29
MERZ NORTH AMERICA, INC.
$29
Merck Sharp & Dohme Corporation
$22
Genentech USA, Inc.
$20
Tactile Systems Technology Inc
$19
Mylan Specialty L.P.
$18
Checkpoint Surgical, Inc
$17
Merck Sharp & Dohme LLC
$17
DAVOL INC.
$17
Novartis Pharmaceuticals Corporation
$16
Bayer HealthCare Pharmaceuticals Inc.
$15
Top 3 companies account for 93.0% of all-time payments
Associated products mentioned in payments ›
ARISTA AH · CIPRODEX · COCHLEAR NUCLEUS CI632 COCHLEAR IMPLANT WITH SLIM MODIOLAR ELECTRODE · Checkpoint Stimulators · Coblation - Laryngeal Wands · DUPIXENT · Dymista · ENTELLUS - XPRESS ENT DILATION SYSTEM · Flexitouch Plus · INC. · INSPIRE · LigaSure · MEDLINE INDUSTRIES · NUCALA · NUVENT · OTOVEL · Otiprio · Otovel · PONTO BONE ANCHORED HEARING SYSTEM · PROPEL · PTeye · Progel · RELIEVA SpinPlus NAV Balloon Sinusplasty System · Ryaltris · SINUVA · STEALTHSTATION S8 PLATFORM · StealthStation · TISSEEL · TruDi NAV Cable · TruDi Navigation System · VIBRANT Soundbridge Middle Ear Implant and BONEBRIDGE System · VIVAER STYLUS · VOQUEZNA · Vitrakvi · XEOMIN · XYWAV · Xeomin · Xhance · Xolair
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (91%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in otolaryngology and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 2% for otolaryngology in PA.

Looking for an otolaryngology specialist in Philadelphia?
Compare otolaryngologists in the Philadelphia area by procedure volume, costs, and industry payment transparency.
Browse otolaryngologists nearby

Geographic Context

Otolaryngologists within 10 mi
247
Per 100K population
15.6
County median income
$60,698
Nearest hospital
THOMAS JEFFERSON UNIVERSITY HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Nagorsky is a clinical cardiology specialist, with above-average Medicare volume (top 4% in PA), with speaking/promotional industry engagement in the top 2% of PA peers, with 20 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Nagorsky experienced with nasal endoscopy?
Based on Medicare claims data, Dr. Nagorsky performed 1,488 nasal endoscopy services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Nagorsky receive payments from pharmaceutical companies?
Yes. Dr. Nagorsky received a total of $70,239 from 41 companies across 395 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Nagorsky's costs compare to other otolaryngologists in Philadelphia?
Dr. Nagorsky's average Medicare payment per service is $102. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Nagorsky) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →